Recherche
-
Treatment-resistant depression in a real-world setting: first interim analysis of characteristics, healthcare resource use, and utility values of the fondaMental cohort
(Brain Sciences. vol. 10, n° 12, pp. 1-16, 2020-12-10)Article de revueLibre accès -
High sensitivity C reactive protein, fibrinogen levels and the onset of major depressive disorder in post-acute coronary syndrome
(BMC Cardiovascular Disorders. vol. 15, pp. 23, 2015-03-18)Article de revueLibre accès -
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials
(Molecular Psychiatry. vol. 27, n° 3, pp. 1286-1299, 2021-12)Article de revueLibre accès -
High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers
(International Journal of Neuropsychopharmacology. vol. 25, n° 6, pp. 468-478, 2022-02-17)Article de revueLibre accès -
Cognitive impairments in treatment-resistant depression: Results from the French cohort of outpatients (FACE-DR)
(Journal of Affective Disorders Reports. vol. 6, pp. 100272, 2021-12-01)Article de revueLibre accès -
Evolution of Cognitive Impairments in Treatment-Resistant Depression: Results from the Longitudinal French Centers of Expertise for Treatment-Resistant Depression (FACE-DR) Cohort.
(Brain Sciences. vol. 13, n° 7, 2023-07-24)Article de revueLibre accès -
EMDR for symptoms of depression, stress and burnout in health care workers exposed to COVID-19 (HARD): A study protocol for a trial within a cohort study.
(European Journal of Psychotraumatology. vol. 14, n° 1, pp. 2179569, 2023-01-01)Article de revueLibre accès -
Relationship between body mass index and neuropsychiatric symptoms: Evidence and inflammatory correlates
(Brain, Behavior, and Immunity. vol. 94, pp. 104-110, 2021-05)Article de revueLibre accès -
Influence of childhood maltreatment on prevalence, onset, and persistence of psychiatric comorbidities and suicide attempts in bipolar disorders
(European Psychiatry. vol. 65, n° 1, 2022-01)Article de revueLibre accès -
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD cohort
(European Neuropsychopharmacology. vol. 77, pp. 67-79, 2023-12-01)Article de revueLibre accès